Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -11,433 | -12,960 |
| Depreciation Amortization | 104 | 180 |
| Accounts payable and accrued liabilities | -1,395 | N/A |
| Other Working Capital | -1,356 | 1,750 |
| Other Operating Activity | 2,128 | -960 |
| Operating Cash Flow | $-11,952 | $-11,990 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -51 | -40 |
| Investing Cash Flow | $-51 | $-40 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 6 | N/A |
| Other Financing Activity | 0 | 23,840 |
| Financing Cash Flow | $6 | $23,840 |
| Beginning Cash Position | 15,068 | 3,260 |
| End Cash Position | 3,071 | 15,060 |
| Net Cash Flow | $-11,997 | $11,790 |
| Free Cash Flow | ||
| Operating Cash Flow | -11,952 | -11,990 |
| Capital Expenditure | -51 | N/A |
| Free Cash Flow | -12,003 | -11,990 |